Research Scientist Matthew Saunders presents at CYTO 2018
Research Scientist Matthew Saunders presented a poster and gave a CYTO Innovation talk on GlycoSenseTM: A Rapid Method for Monitoring In...
Read moreResearch Scientist Matthew Saunders presented a poster and gave a CYTO Innovation talk on GlycoSenseTM: A Rapid Method for Monitoring In...
Read moreInterim CEO and CSO Lori Yang presented two posters and gave a talk on GlycoSenseTM: A Rapid Method for Monitoring In Vitro Glycoengineering...
Read moreDirector of Operations Sean Wu presented a poster and gave a talk on sialoglycoconjugate detection and enrichment products. Learn more about...
Read moreThe Lectenz Bio team is excited to announce the approval of its patent for the Lectenz® platform technology. This paves the way for more...
Read moreThe National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to further develop sialic...
Read moreThe National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio a second SBIR Phase I to apply the...
Read moreLectenz Bio receives a U01 from the NIH Common Fund Glycoscience program to further develop GlycoSenseTM technology. Lectenz Bio receives an SBIR...
Read moreDr. Lori Yang, co-Founder and CSO of Lectenz Bio, will be a featured panelist at San Diego Startup Week on June 20th. Dr. Yang will share about...
Read moreProf. Robert J. Woods, President and co-Founder, and collaborators reported in PLoS Pathogens on Thursday, June 15th that three mutations switch...
Read moreThe Lectenz Bio team is excited to announce the approval of its first patent for a carbohydrate-like small molecule inhibitor. This expands the...
Read moreLectenz Bio’s Chief Scientific Officer and co-founder Lori Yang was recently interviewed by JLabs for her work on International...
Read moreLectenz Bio team was selected to participate as semi-finalists for the 2016 Thermo Fisher Scientific Innovation Day. This unique program is set up...
Read more